{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:40Z","timestamp":1746417760715,"version":"3.40.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Stanniocalcin-1 (STC1) takes part in anti-inflammatory and anti-oxidative processes, thus demonstrating neuroprotective properties. Early brain injuries associated with initial subarachnoid hemorrhage typically led to secondary cerebral infarction and poor outcomes. This retrospective study aimed to clarify the clinical significance of serum STC1 level in patients with subarachnoid hemorrhage.<\/jats:p>\n            <jats:p>We collected demographic information, comorbidities, neurological status in detail. All blood samples were collected on admission. Enzyme-linked immunosorbent assay kits were used to detect the serum level of STC1. Spearman analysis was used to explore the relationship between STC1 and clinical severity. Multivariate logistic regression was used to investigate the prognostic role of STC1 in patients with aneurysmal subarachnoid hemorrhage (aSAH). Receiver operating characteristic curve was performed to investigate the power of STC1 in predicting outcome in aSAH patients.<\/jats:p>\n            <jats:p>Serum STC1 concentration was significantly higher in aSAH patients than in healthy individuals. Serum concentration of STC1 positively correlated with Hunt-Hess grade (r\u200a=\u200a0.62, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01) and Fisher grade (r\u200a=\u200a0.48, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01), and negatively correlated with Glasgow Coma Scale on admission (r\u200a=\u200a\u22120.45, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01). Patients with delayed cerebral ischemia (DCI) had higher level of serum STC1 than those without DCI (13.12\u200a\u00b1\u200a1.44 vs 8.56\u200a\u00b1\u200a0.31, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01). Moreover, patients with poor outcome had higher concentration of STC1 than patients with good outcome (11.82\u200a\u00b1\u200a0.62 vs 8.21\u200a\u00b1\u200a0.35,<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.01). Results of univariate and multivariate logistic analysis revealed that Hunt-hess III\u2013IV, DCI, and high STC1 level were independent risk factors associated with poor outcome of patients with aSAH. Further analysis revealed that combination of STC1 with Hunt-hess grade was more superior to 2 indicators alone in predicting clinical outcome of aSAH patients.<\/jats:p>\n            <jats:p>STC1 can be used as a novel biomarker in predicting outcome of patients with aSAH, especially when combined with Hunt-hess grade.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028222","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T19:34:47Z","timestamp":1640288087000},"page":"e28222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Early-stage serum Stanniocalcin 1 as a predictor of outcome in patients with aneurysmal subarachnoid hemorrhage"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-5710","authenticated-orcid":false,"given":"Qin","family":"Jun","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, the Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Liuzhou City, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijian","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shenzhen People's Hospital, Second Clinical Medical College of Ji\u2019nan University, Shenzhen, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fneur.2018.00583","article-title":"The epidemiological characteristics of stroke in Hunan Province, China","volume":"9","author":"He","year":"2018","journal-title":"Front Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.wneu.2016.11.006","article-title":"Patterns of stroke between university hospitals and nonuniversity hospitals in mainland china: prospective multicenter hospital-based registry study","volume":"98","author":"Wang","year":"2017","journal-title":"World Neurosurg"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.wneu.2017.05.005","article-title":"What factors determine treatment outcome in aneurysmal subarachnoid hemorrhage in the modern era? A post hoc STASH analysis","volume":"105","author":"Teo","year":"2017","journal-title":"World Neurosurg"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.wneu.2014.12.032","article-title":"Modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading system","volume":"83","author":"Sano","year":"2015","journal-title":"World Neurosurg"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01376517-200212000-00002","article-title":"Grading scales used in the management of aneurysmal subarachnoid hemorrhage: a critical review","volume":"34","author":"Cavanagh","year":"2002","journal-title":"J Neurosci Nurs"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10143-018-1037-y","article-title":"Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review","volume":"43","author":"Jabbarli","year":"2018","journal-title":"Neurosurg Rev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4103\/1673-5374.235022","article-title":"Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage","volume":"13","author":"Suzuki","year":"2018","journal-title":"Neural Regen Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/STROKEAHA.111.639161","article-title":"Accuracy of neurovascular fellows\u2019 prognostication of outcome after subarachnoid hemorrhage","volume":"43","author":"Navi","year":"2012","journal-title":"Stroke"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mce.2015.01.010","article-title":"STC1 interference on calcitonin family of receptors signaling during osteoblastogenesis via adenylate cyclase inhibition","volume":"403","author":"Terra","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.peptides.2004.04.015","article-title":"Stanniocalcin 1 as a pleiotropic factor in mammals","volume":"25","author":"Yoshiko","year":"2004","journal-title":"Peptides"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trsl.2016.06.011","article-title":"Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes\/macrophages to inflammatory stimuli","volume":"177","author":"Mohammadipoor","year":"2016","journal-title":"Transl Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1007\/s13277-015-3319-0","article-title":"Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients","volume":"36","author":"Su","year":"2015","journal-title":"Tumour Biol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2017.11.033","article-title":"Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1","volume":"416","author":"Li","year":"2018","journal-title":"Cancer Lett"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/pmic.201300554","article-title":"Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors","volume":"14","author":"Yoon","year":"2014","journal-title":"Proteomics"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.peptides.2011.06.004","article-title":"PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells","volume":"32","author":"Holighaus","year":"2011","journal-title":"Peptides"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2008.08.158","article-title":"Identification of STC1 as an beta-amyloid activated gene in human brain microvascular endothelial cells using cDNA microarray","volume":"376","author":"Li","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.10.062","article-title":"Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance","volume":"229","author":"Durukan","year":"2013","journal-title":"Neuroscience"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.STR.0000258113.67252.fa","article-title":"Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling","volume":"38","author":"Westberg","year":"2007","journal-title":"Stroke"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"k102","DOI":"10.1136\/bmj.k102","article-title":"Predicting outcomes in aneurysmal subarachnoid haemorrhage","volume":"360","author":"Nath","year":"2018","journal-title":"BMJ"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.wneu.2017.09.074","article-title":"Prognostic value of early S100 calcium binding protein B and neuron-specific enolase in patients with poor-grade aneurysmal subarachnoid hemorrhage: a pilot study","volume":"108","author":"Abboud","year":"2017","journal-title":"World Neurosurg"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/S0004-282X2012000300009","article-title":"Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage","volume":"70","author":"Romero","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4103\/1673-5374.221158","article-title":"D-dimer may predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage: a retrospective study","volume":"12","author":"Liu","year":"2017","journal-title":"Neural Regen Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.peptides.2014.04.001","article-title":"Circulating levels of neuropeptide proenkephalin A predict outcome in patients with aneurysmal subarachnoid hemorrhage","volume":"56","author":"Chen","year":"2014","journal-title":"Peptides"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1742-2094-9-194","article-title":"Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage","volume":"9","author":"Zhu","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"R288","DOI":"10.1186\/cc10575","article-title":"Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage","volume":"15","author":"Zhu","year":"2011","journal-title":"Crit Care"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1016\/j.peptides.2014.06.014","article-title":"Identification of plasma adrenomedullin as a possible prognostic biomarker for aneurysmal subarachnoid hemorrhage","volume":"59","author":"Cai","year":"2014","journal-title":"Peptides"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.thromres.2015.03.025","article-title":"The prognostic value of plasma soluble CD40 ligand levels following aneurysmal subarachnoid hemorrhage","volume":"136","author":"Chen","year":"2015","journal-title":"Thromb Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:07:31Z","timestamp":1746338851000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":27,"journal-issue":{"issue":"51","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028222","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"assertion":[{"value":"2021-04-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}